These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31867887)

  • 1. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.
    Nagase T; Iwaya K; Kogure K; Zako T; Misumi Y; Kikuchi M; Matsumoto K; Noritake M; Kawachi Y; Kobayashi M; Ando Y; Katsura Y
    J Diabetes Investig; 2020 Jul; 11(4):1002-1005. PubMed ID: 31867887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-derived amyloidosis and poor glycemic control: a case series.
    Nagase T; Iwaya K; Iwaki Y; Kotake F; Uchida R; Oh-i T; Sekine H; Miwa K; Murakami S; Odaka T; Kure M; Nemoto Y; Noritake M; Katsura Y
    Am J Med; 2014 May; 127(5):450-4. PubMed ID: 24462809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity of insulin-derived amyloidosis: a case report.
    Iwaya K; Zako T; Fukunaga J; Sörgjerd KM; Ogata K; Kogure K; Kosano H; Noritake M; Maeda M; Ando Y; Katsura Y; Nagase T
    BMC Endocr Disord; 2019 Jun; 19(1):61. PubMed ID: 31196059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection.
    Kudo-Watanuki S; Kurihara E; Yamamoto K; Mukai K; Chen KR
    Clin Exp Dermatol; 2013 Jan; 38(1):25-9. PubMed ID: 22924529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
    Ansari AM; Osmani L; Matsangos AE; Li QK
    Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Histologic Finding of Amyloid Insulin Bodies at an Insulin Injection Site in a Patient With Diabetes.
    Katzman BD; Traum P; Medline PB
    Am J Dermatopathol; 2018 Jul; 40(7):527-530. PubMed ID: 29135508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why and by How Much is Insulin Absorption Reduced by Insulin-derived Amyloidosis? A Scoping Review.
    Ibuki A; Fukuda M; Akase T; Sugama J; Yanagita T
    Yakugaku Zasshi; 2023; 143(10):865-870. PubMed ID: 37779016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 11. Localized cutaneous amyloid at an insulin injection site.
    Lonsdale-Eccles AA; Gonda P; Gilbertson JA; Haworth AE
    Clin Exp Dermatol; 2009 Dec; 34(8):e1027-8. PubMed ID: 20055830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intensive insulin therapy in type 2 diabetes mellitus].
    Jermendy G
    Orv Hetil; 2012 Sep; 153(38):1487-93. PubMed ID: 22985663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient.
    Shikama Y; Kitazawa J; Yagihashi N; Uehara O; Murata Y; Yajima N; Wada R; Yagihashi S
    Intern Med; 2010; 49(5):397-401. PubMed ID: 20190472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonography Improves Glycemic Control by Detecting Insulin-Derived Localized Amyloidosis.
    Kikuchi M; Hirokawa N; Hagiwara S; Nakayama H; Taneda S; Manda N; Sakata K
    Ultrasound Med Biol; 2017 Oct; 43(10):2284-2294. PubMed ID: 28754497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.
    Yumlu S; Barany R; Eriksson M; Röcken C
    Hum Pathol; 2009 Nov; 40(11):1655-60. PubMed ID: 19683329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular amyloidosis at the sites of insulin injections.
    Bernárdez C; Schärer L; Molina-Ruiz AM; Requena L
    J Cutan Pathol; 2015 Jul; 42(7):496-502. PubMed ID: 25953111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized insulin amyloidosis with use of concentrated insulin: a potential complication.
    Mangla A; Kim GJ; Agarwal N; Khurana S; Catchatourian R; Jiang JJ
    Diabet Med; 2016 Dec; 33(12):e32-e35. PubMed ID: 27087031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
    Phua EJ; Lopez X; Ramus J; Goldfine AB
    Diabetes Care; 2013 Dec; 36(12):e204-5. PubMed ID: 24265375
    [No Abstract]   [Full Text] [Related]  

  • 19. Case of type 2 diabetes mellitus with edema resulting in subcutaneous insulin resistance syndrome.
    Hu Y; Zhu Q; Yang X; Yan J; Shi J
    J Diabetes Investig; 2021 Dec; 12(12):2267-2270. PubMed ID: 34102011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
    Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
    Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.